Dysfibrinogenaemia and liver cell growth. Journal Articles

abstract

• From the evidence presented, it is proposed that 'dysfibrinogenaemia' represents the production of normal fetal fibrinogen by rapidly proliferating liver cells in both regenerating and neoplastic tissue. Prolongation of the reptilase clotting time, which was formerly believed to reflect dysfibrinogenaemia, may be rather the result of hepatocytic death.

authors

• Barr, Ronald Duncan
• Allardyce, M
• Brunt, PW
• McPhie, JL

status

• published 

publication date

• January 1978

has subject area

• 1103 Clinical Sciences (FoR)
• 1108 Medical Microbiology (FoR)
• Batroxobin (MeSH)
• Blood Coagulation Disorders (MeSH)
• Blood Coagulation Tests (MeSH)
• Fibrinogen (MeSH)
• Humans (MeSH)
• Liver Diseases (MeSH)
• Liver Neoplasms (MeSH)
• Liver Regeneration (MeSH)
• Pathology (Science Metrix)

published in

• Journal of Clinical Pathology - Clinical Molecular Pathology  Journal

keywords

• Batroxobin
• Blood Coagulation Disorders
• Blood Coagulation Tests
• Fibrinogen
• Humans
• Liver Diseases
• Liver Neoplasms
• Liver Regeneration

Digital Object Identifier (DOI)

• 10.1136/jcp.31.1.89

start page

• 89

end page

• 92

volume

• 31

issue

• 1